Past, present and future of therapies in pediatric sarcomas. - Test2 - elhamkhani - TriplyDB

Past, present and future of therapies in pediatric sarcomas.

Past, present and future of therapies in pediatric sarcomas.

http://www.wikidata.org/entity/Q37725915

about

Educational paper. The development of new therapies for pediatric oncology.Progress of oncolytic viruses in sarcomas.

P2860

Q37824438-EEC48AA6-E45D-4E71-9971-D8D2EA7F858F Q37982449-DC83A6D4-673C-4FF0-8F1F-784143153E56

P2860

Past, present and future of therapies in pediatric sarcomas.

http://www.wikidata.org/entity/Q37725915

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Past, present and future of therapies in pediatric sarcomas.

@en

Past, present and future of therapies in pediatric sarcomas.

@nl

type

label

Past, present and future of therapies in pediatric sarcomas.

@en

Past, present and future of therapies in pediatric sarcomas.

@nl

prefLabel

Past, present and future of therapies in pediatric sarcomas.

@en

Past, present and future of therapies in pediatric sarcomas.

@nl

P1433

Q37725915-87581637-602D-4D83-8A19-AB773414AB1F

P1476

Q37725915-F55B99B3-3849-4EA8-8E3C-E29FE1CF0F12

P2093

Q37725915-28885800-0325-4ED6-BFEE-4EB8A149CEE1

Q37725915-4E939497-45BF-47AC-9FE1-F0869EB39426

P2860

Q37725915-05ACB3B4-5E72-420D-8F23-D61DAC39521D

Q37725915-090B156D-7AE6-4168-98C0-9FC815FE669A

Q37725915-0BF44FF7-6D69-406A-ADFC-EE2BB3EC45BE

Q37725915-0C9E7A8C-CA28-487D-A8C9-D42E0257730E

Q37725915-1148E4D6-1454-4326-A570-85D91DC05B7D

Q37725915-1A5455E4-337C-41B8-8FFF-3E75DA333875

Q37725915-1CA24F2F-93CC-4F09-9F4D-5088E524E528

Q37725915-1E709B70-29F9-4650-AB1B-08FC052E179E

Q37725915-243D8F72-4D28-4B72-9911-AD552708F584

Q37725915-2600B59F-95C4-4627-A865-E104825A492F

P304

Q37725915-DB335015-FB71-4298-8B39-96B37D5D220E

P31

Q37725915-7C7FA2A2-1077-496B-A229-BA4695DCCE84

P356

Q37725915-5BCA3562-84F8-4FEE-B325-37D752FAB87C

P407

Q37725915-B3E9ABCE-BCCD-4FAD-94DF-C57E5FF3E010

P433

Q37725915-81798EF0-0B14-49C8-ACEB-400EA34B66F6

P478

Q37725915-2180F16F-9077-445E-9941-ED62DED8A912

P577

Q37725915-F4A03292-25A1-4605-89B8-102DBF4DD2AA

P698

Q37725915-DE1DC8AF-F456-4D81-A86C-D768A08A4882

P356

P1433

Future Oncology

P1476

Past, present and future of therapies in pediatric sarcomas.

@en

P2093

Edward A Kolb

http://www.w3.org/2001/XMLSchema#string

Pooja Hingorani

http://www.w3.org/2001/XMLSchema#string

P2860

The phosphoinositide 3-kinase pathway

Role of insulin-like growth factor binding proteins in the control of IGF actions

Insulin-like growth factor-I receptor signal transduction: at the interface between physiology and cell biology

Changes in incidence and survival of Ewing sarcoma patients over the past 3 decades: Surveillance Epidemiology and End Results data.

Ecteinascidin-743 (ET-743), a natural marine compound, with a unique mechanism of action.

A phase II study of ET-743/trabectedin ('Yondelis') for patients with advanced gastrointestinal stromal tumours.

Pazopanib, a multikinase angiogenesis inhibitor, in patients with relapsed or refractory advanced soft tissue sarcoma: a phase II study from the European organisation for research and treatment of cancer-soft tissue and bone sarcoma group (EORTC stu

Sorafenib blocks tumour growth, angiogenesis and metastatic potential in preclinical models of osteosarcoma through a mechanism potentially involving the inhibition of ERK1/2, MCL-1 and ezrin pathways.

Phase I pharmacokinetic and pharmacodynamic study of the oral mammalian target of rapamycin inhibitor everolimus in patients with advanced solid tumors.

Biology of EWS/ETS fusions in Ewing's family tumors.

P304

605-618

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/FON.10.19

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2010-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20373872

http://www.w3.org/2001/XMLSchema#string